D.A. Davidson & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1M Buy
180,608
+2,009
+1% +$162K 0.08% 205
2026
Q1
$15.5M Sell
178,599
-18,409
-9% -$1.76M 0.09% 172
2025
Q4
$18.9M Sell
197,008
-16,474
-8% -$1.6M 0.12% 138
2025
Q3
$20.3M Sell
213,482
-23,382
-10% -$2.15M 0.13% 126
2025
Q2
$20.6M Buy
236,864
+3,644
+2% +$309K 0.15% 116
2025
Q1
$21M Buy
233,220
+19,015
+9% +$1.7M 0.17% 105
2024
Q4
$17.1M Buy
214,205
+138
+0.1% +$11.9K 0.14% 121
2024
Q3
$19.3M Sell
214,067
-2,501
-1% -$210K 0.16% 104
2024
Q2
$17M Buy
216,568
+9,399
+5% +$771K 0.15% 106
2024
Q1
$18.1M Buy
207,169
+43,769
+27% +$3.74M 0.16% 106
2023
Q4
$13.5M Buy
163,400
+4,904
+3% +$374K 0.13% 121
2023
Q3
$12.4M Buy
158,496
+6,930
+5% +$580K 0.13% 124
2023
Q2
$13.4M Buy
151,566
+24,655
+19% +$2.12M 0.14% 117
2023
Q1
$10.2M Buy
126,911
+12,583
+11% +$1.03M 0.11% 140
2022
Q4
$8.89M Sell
114,328
-1,551
-1% -$126K 0.1% 167
2022
Q3
$9.37M Buy
115,879
+2,256
+2% +$203K 0.12% 134
2022
Q2
$10.2M Buy
113,623
+4,375
+4% +$443K 0.13% 130
2022
Q1
$12.1M Buy
109,248
+5,049
+5% +$533K 0.13% 126
2021
Q4
$10.8M Buy
104,199
+1,132
+1% +$131K 0.12% 144
2021
Q3
$12.9M Buy
103,067
+455
+0.4% +$58.9K 0.15% 116
2021
Q2
$12.7M Buy
102,612
+2,712
+3% +$341K 0.15% 116
2021
Q1
$11.8M Buy
99,900
+13,221
+15% +$1.55M 0.15% 114
2020
Q4
$10.1M Sell
86,679
-2,598
-3% -$286K 0.16% 108
2020
Q3
$9.28M Buy
89,277
+1,552
+2% +$156K 0.16% 104
2020
Q2
$8.04M Sell
87,725
-7,696
-8% -$738K 0.15% 111
2020
Q1
$8.63M Buy
95,421
+5,922
+7% +$630K 0.17% 103
2019
Q4
$10.1M Buy
89,499
+8,647
+11% +$949K 0.16% 102
2019
Q3
$8.78M Buy
80,852
+888
+1% +$92.6K 0.16% 107
2019
Q2
$7.79M Sell
79,964
-21,018
-21% -$1.92M 0.15% 114
2019
Q1
$9.2M Buy
100,982
+916
+0.9% +$82K 0.16% 109
2018
Q4
$9.1M Sell
100,066
-973
-1% -$90.9K 0.18% 96
2018
Q3
$9.94M Buy
101,039
+3,023
+3% +$279K 0.18% 100
2018
Q2
$8.39M Buy
98,016
+3,961
+4% +$331K 0.16% 105
2018
Q1
$7.54M Buy
94,055
+993
+1% +$81.9K 0.16% 113
2017
Q4
$7.51M Buy
93,062
+9,805
+12% +$785K 0.16% 112
2017
Q3
$6.47M Sell
83,257
-1,296
-2% -$108K 0.13% 164
2017
Q2
$7.5M Buy
84,553
+3,293
+4% +$278K 0.17% 109
2017
Q1
$6.55M Sell
81,260
-7,419
-8% -$580K 0.16% 116
2016
Q4
$6.31M Buy
88,679
+15,701
+22% +$1.23M 0.14% 142
2016
Q3
$6.3M Buy
72,978
+33,929
+87% +$2.96M 0.16% 135
2016
Q2
$3.38M Sell
39,049
-7,739
-17% -$626K 0.1% 194
2016
Q1
$3.5M Buy
46,788
+7,188
+18% +$541K 0.11% 186
2015
Q4
$3.04M Sell
39,600
-736
-2% -$55.4K 0.1% 196
2015
Q3
$2.69M Buy
40,336
+301
+0.8% +$22.2K 0.09% 209
2015
Q2
$2.96M Sell
40,035
-2,041
-5% -$156K 0.1% 205
2015
Q1
$3.28M Buy
42,076
+16,285
+63% +$1.23M 0.11% 195
2014
Q4
$1.86M Buy
25,791
+3,098
+14% +$215K 0.06% 284
2014
Q3
$1.4M Buy
22,693
+1,576
+7% +$100K 0.05% 340
2014
Q2
$1.34M Buy
21,117
+1,649
+8% +$100K 0.05% 357
2014
Q1
$1.2M Sell
19,468
-2,157
-10% -$126K 0.04% 364
2013
Q4
$1.24M Buy
21,625
+1,836
+9% +$104K 0.05% 341
2013
Q3
$1.05M Sell
19,789
-1,289
-6% -$69.4K 0.05% 345
2013
Q2
$1.08M Buy
+21,078
New +$1.04M 0.05% 309

Other funds holding MDT

D.A. Davidson & Co's MDT Position: Q2 2026 in Review

D.A. Davidson & Co increased its Medtronic (MDT) stake by 1.1% in Q2 2026, buying an estimated $162K and bringing the position to 180,608 shares worth $14.1M. The position accounts for 0.08% of the portfolio, ranked #205.

D.A. Davidson & Co first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $21M in Q1 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • D.A. Davidson & Co held 180,608 shares of Medtronic worth $14.1M as of Q2 2026.
  • D.A. Davidson & Co bought 2,009 Medtronic shares in Q2 2026, an estimated $162K.
  • Medtronic made up 0.08% of D.A. Davidson & Co's portfolio in Q2 2026, its #205 holding.
  • D.A. Davidson & Co first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • D.A. Davidson & Co's Medtronic position peaked at $21M in Q1 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.